XyberCyl is a hernia repair solution designed to be complication-free, fostering natural tissue growth and enabling the abdominal wall to heal itself with a long-term resolution.
- General Details
XyberCyl presents a revolutionary approach to ventral hernia repair, boasting a monofilament silicone material designed with patented wide-open spaces. Unlike traditional surgical meshes that often lead to complications, XyberCyl’s innovative design aims to prevent irritation and foreign body reactions, ensuring a complication-free experience. By harnessing the body’s natural healing capabilities within its environment, XyberCyl facilitates robust healing and offers a permanent solution to ventral hernia defects. It serves as a biologically invisible mechanical support, stabilizing the abdominal wall without triggering foreign body reactions or associated complications, thus enabling physiological and lasting hernia repair.
- Patent Portfolio
The IP and assets available for sale include:
- Patent No. US-10792142-B2 – Entitled “Implantable areal device for supporting tissue”
- Publication No. US20180168791A1 – Entitled “Implantable areal device for supporting tissue”
- Publication No. US-20210204981-A1 – Entitled “Implantable Tissue Stabilizing Structure for in situ Muscle Regeneration”
- Publication No. US20200069844A1 – Entitled “Implantable Tissue Stabilizing Structure for in situ Muscle Regeneration”
- Publication No. US20200069408A1 – Entitled “Implantable Tissue Stabilizing Structure for in situ Muscle Regeneration”
- Patent No. EP2819616B1 – Entitled “Tissue Support Structure”
- Publication No. EP3705086-A1 – Entitled “Implantable Tissue Stabilizing Structure for in Situ Muscle Regeneration”
- Licensees
This intellectual property may be of interest to companies similar to the following:
· Healionics · Medtronics · Viscus Biologics · Allergan · Johnson & Johnson · Becton, Dickinson and Company (BD) · Sanofi SA · Atrium Medical · B. Braun Melsungen · Gore Medical · Evonik · Tela Bio · 3M · Boston Scientific - Pricing, Data Room Access & Additional Details
Other Publicly Data Room Materials Are Available at: Link to VIP-3297 Public Data Room
- Introductory Material
- Patents and Patent Applications
- Patent File Histories
- Additional Information Regarding Ventral Hernia and Related Products
- Non-Disclosure Agreement Draft to access more files listed below
Additional Materials (available upon signing mutual non-disclosure agreement):
- Due Diligence Review
- Patent Assignments and Ownership
- The Conception and Development of XyberCyl
- Presentations and Clinical Trials
- Market Data
- Benefits of XyberCyl
Contact sales@vibrantip.com for pricing guidance, data room access, and additional information.
Proof of concept and working prototypes may be available.
- More Information
Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Peter Johnson at Vibrant IP, LLC at peter@vibrantip.com and 435-999-3600.